When chemotherapy was too risky: How a 2-year-old survived rare blood cancer with precision treatment
A rare childhood blood cancer case highlights a shift towards personalized medicine. Instead of harsh chemotherapy, a young patient thrived on a targeted oral treatment, living a normal life years later. This innovative approach, though not universally accessible, offers hope for difficult childhood cancers, emphasizing early detection and equitable access to advanced therapies.
A rare childhood blood cancer case highlights a shift towards personalized medicine. Instead of harsh chemotherapy, a young patient thrived on a targeted oral treatment, living a normal life years later. This innovative approach, though not universally accessible, offers hope for difficult childhood cancers, emphasizing early detection and equitable access to advanced therapies.
